ArticleHemaSphere2025

Efficacy of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma and prior central nervous system manifestation: A multicenter real-world analysis.

Markus Maulhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.